Literature DB >> 33525835

The human archaeome: methodological pitfalls and knowledge gaps.

Alexander Mahnert1,2, Marcus Blohs1, Manuela-Raluca Pausan1, Christine Moissl-Eichinger1,2.   

Abstract

Forty years ago, archaea were described as a separate domain of life, distinct from bacteria and eukarya. Although it is known for quite a long time that methanogenic archaea are substantial components of the human gastrointestinal tract (GIT) and the oral cavity, the knowledge on the human archaeome is very limited. Various methodological problems contribute to the invisibility of the human archaeome, resulting in severe knowledge gaps and contradictory information. Similar to the bacteriome, the archaeal biogeography was found to be site-specific, forming (i) the thaumarchaeal skin landscape, (ii) the (methano)euryarchaeal GIT landscape, (iii) a mixed skin/GIT landscape in nose, and (iv) a woesearchaeal lung landscape, including numerous unknown archaeal clades. Compared with so-called universal microbiome approaches, archaea-specific protocols reveal a wide diversity and high quantity of archaeal signatures in various human tissues, with up to 1 : 1 ratios of bacteria and archaea in appendix and nose samples. The archaeome interacts closely with the bacteriome and the human body cells, whereas the roles of the human-associated archaea with respect to human health are only sparsely described. Methanogenic archaea and methane production were correlated with many health issues, including constipation, periodontitis and multiple sclerosis. However, one of the most burning questions - do archaeal pathogens exist? - still remains obscure to date.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society and the Royal Society of Biology.

Entities:  

Keywords:  archaea; archaeome; microbiome

Year:  2018        PMID: 33525835     DOI: 10.1042/ETLS20180037

Source DB:  PubMed          Journal:  Emerg Top Life Sci        ISSN: 2397-8554


  4 in total

Review 1.  Methanogenic archaea in the human gastrointestinal tract.

Authors:  Christoph Hoegenauer; Heinz F Hammer; Alexander Mahnert; Christine Moissl-Eichinger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-01       Impact factor: 73.082

Review 2.  Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease.

Authors:  Yashar Houshyar; Luca Massimino; Luigi Antonio Lamparelli; Silvio Danese; Federica Ungaro
Journal:  Front Physiol       Date:  2021-12-06       Impact factor: 4.566

Review 3.  Updating changes in human gut microbial communities associated with Clostridioides difficile infection.

Authors:  Giovanny Herrera; Daniel Paredes-Sabja; Manuel Alfonso Patarroyo; Juan David Ramírez; Marina Muñoz
Journal:  Gut Microbes       Date:  2021 Jan-Dec

4.  Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain.

Authors:  Aimée Parker; Stefano Romano; Rebecca Ansorge; Asmaa Aboelnour; Gwenaelle Le Gall; George M Savva; Matthew G Pontifex; Andrea Telatin; David Baker; Emily Jones; David Vauzour; Steven Rudder; L Ashley Blackshaw; Glen Jeffery; Simon R Carding
Journal:  Microbiome       Date:  2022-04-29       Impact factor: 16.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.